Obesity, Diabetes, and Birth Outcomes Among American Indians and Alaska Natives

Kermyt G Anderson1, Paul Spicer2,3, Michael T Peercy4

  • 1Department of Anthropology, University of Oklahoma, 521 Dale Hall Tower, 455 West Lindsey, Norman, OK, 73019, USA. kganders@ou.edu.

Insights

American Indians and Alaska Natives (AI/AN) experience higher diabetes rates, but unlike other groups, prepregnancy weight does not predict preterm birth. Diabetes increases preterm birth risk for all groups, and all studied factors increase macrosomia risk.

Area of Science:

  • Reproductive health
  • Maternal-fetal medicine
  • Health disparities

Background:

  • Prepregnancy diabetes mellitus (DM), gestational diabetes mellitus (GDM), and prepregnancy body mass index (BMI) are associated with adverse birth outcomes.
  • Significant racial and ethnic disparities exist in diabetes and obesity rates in the US.

Purpose of the Study:

  • To compare the associations of DM, GDM, and prepregnancy BMI with preterm delivery (PTB), low birthweight (LBW), and macrosomia.
  • To specifically examine these relationships in American Indian and Alaska Native (AI/AN) populations compared to other race/ethnic groups.

Main Methods:

  • Analysis of 5,193,386 singleton US first births from 2009-2013.
  • Logistic regression models were used to calculate adjusted odds ratios.
  • Covariates included calendar year, maternal age, education, marital status, prenatal care index, and child's sex.

Main Results:

  • AI/AN populations exhibit higher rates of diabetes, overweight, and obesity compared to other groups.
  • Prepregnancy overweight or obesity did not predict PTB for AI/AN, contrasting with other groups. Diabetes predicted increased PTB odds for all groups.
  • Overweight was associated with reduced LBW odds for all groups, but obesity and diabetes were not predictive of LBW for AI/AN. DM, GDM, overweight, and obesity all predicted higher odds of macrosomia across all groups.

Conclusions:

  • Diabetes in pregnancy and prepregnancy weight management are crucial for reducing PTB and macrosomia, particularly among AI/AN women.
  • Understanding race/ethnic differences in the impact of metabolic and weight factors on birth outcomes is essential for targeted interventions.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.2K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
351
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
330
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.7K